Capstone Therapeutics Corp. 4
4 · Capstone Therapeutics Corp. · Filed Jan 3, 2012
Insider Transaction Report
Form 4
HOLLIMAN JOHN M III
DirectorExecutive Chairman
Transactions
- Award
Common Stock
2012-01-01+10,000→ 332,614 total - Award
Stock Option (Right to Buy)
2012-01-01+10,000→ 715,000 totalExercise: $0.26From: 2012-01-01Exp: 2022-01-01→ Common Stock (10,000 underlying)
Holdings
- 1,568(indirect: Valley Ventures III, LP)
Common Stock
- 3,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents 10,000 shares of restricted stock issued pursuant to the Capstone Therapeutics Corp. 2005 Equity Incentive Plan, which are subject to a risk of forfeiture until vesting on 1-2-2013.